People · Operator
Named in public records as an officer, director or promoter · active 2015–2021 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ShouTi Inc. | — | Biotechnology | Series D+ | $165.0M | $178.2M | 2019 |
| Semma Therapeutics, Inc. | — | Biotechnology | Series D+ | $129.3M | $4.7B | 2017 |
| EdgeMakers, Inc. | — | Other Technology | Series A | $13.1M | $277.5M | 2015 |
Daniel Auerbach at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Auerbach on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| RICHARD LEVANDOV | 1 | 20 |
| Todd Foley | 1 | 12 |
| Robert Weisskoff | 1 | 12 |
| RICH LEVANDOV | 1 | 8 |
| STEPHEN KNIGHT | 1 | 6 |
| Ramy Farid | 1 | 5 |
| Kevin Raidy | 1 | 4 |
| Raymond Stevens | 1 | 3 |
| Robert Millman | 1 | 3 |
| Mark Fishman | 1 | 3 |
| Mitchell Finer | 1 | 3 |
| Bastiano Sanna | 1 | 2 |
| Chen-Ming Yu | 1 | 2 |
| Jim Scopa | 1 | 2 |
| Mitch Finer | 1 | 2 |
| William Sahlman | 1 | 2 |
| Elizabeth Stoner | 1 | 2 |
| Jun Yoon | 1 | 1 |
| Kingsley Taft | 1 | 1 |
| Ting Xie | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.